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INTRODUCTION:  Paragangliomas  are tumors  that  arise  from  extraadrenal  chromaffin  cells  and  most
of them  are  asymptomatic  presenting  with  painless  mass.  Retroperitoneal  paragangliomas  are  mostly
benign  with  good  prognosis;  however,  they  can present  with  abdominal  pain,  palpable  mass,  or hyper-
tensive  episodes.  Surgical  resection  is  still the  main  treatment  and  necessary  for  histological  assessment.
CASE  REPORT:  A 41  year  old  female  patient  presented  with  6 months  of loss  of  appetite,  weight  loss,
weakness  and breathlessness  on exertion..  The  patient’s  initial  blood  examination  showed  marked  ane-
mia, reduced  leukocyte  count  with  neutropenia  and  lymphopenia  and  a marked  reduction  in the  platelet
count.  The  patient  was  admitted  for evaluation  of  her pancytopenia.  Magnetic  resonance  imaging  revealed
a  8 × 7  × 8  cm  sized  mass  closed  to the  pancreatic  tail invading  splenic  hilum.  A  large  mass  was  identified
retroperitoneally,  closed  to  the  tail  of  pancreas  with  a splenic  hilum  invasion.  Total  mass  resection  and
splenectomy  was performed.
DISCUSSION:  Complete  surgical  excision  is  the  treatment  of  choice  for extra-adrenal  paragangliomas  as
well as for  recurrent  or  metastatic  neoplasms.  Reactive  thrombocytosis  is  a  common  cause  of  thrombocy-
tosis.  Splenectomy  was  found  to be  one  of the  main  causes  of extreme  reactive  thrombocytosis.  Reactive
thrombocytosis  is a  predictable  finding  after  splenectomy  and  management  of the  thrombocytosis  and
prevention  of  complications  should  be  initiated.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Paragangliomas are tumors that arise from extraadrenal chro-
maffin cells and can develope at various sites of the body including
the head, neck, thorax and the abdomen. Most of the paragan-
gliomas are asymptomatic presenting with painless mass. About
75% of paragangliomas are sporadic and 85% of paragangliomas
develop in the abdominal cavity [1].
When presenting within the abdominal cavity, they may  arise as
a primary retroperitoneal neoplasm and can mimic  vascular mal-
formations or other conditions related to specific retroperitoneal
organs such as the pancreas, kidneys, or adrenals. Retroperitoneal
paragangliomas arise from specialized neural crest derived cells
distributed along the aorta in association with the sympathetic
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chain. Retroperitoneal paragangliomas mainly affect adults who
are in the fourth or fifth decade of life, and they have no sex
predilection [2]. Retroperitoneal paragangliomas are mostly benign
with good prognosis; however, they can present with abdomi-
nal pain, palpable mass, or hypertensive episodes [3]. Patients
with secretory tumors experience paroxysmal episodic hyperten-
sion, as well as the typical triad of symptoms associated with
pheochromocytomas, for example, palpitations, headache and
sweating. Nonfunctional paragangliomas most commonly manifest
as abdominal pain or a mass [4]. In the present case, we report a
rare case of a retroperitoneal paraganglioma presenting with pan-
cytopenia.
2. Case report
A 41 year old female patient presented with 6 months of loss
of appetite, weight loss, weakness, and breathlessness on exer-
tion. There was  no history of smoking and alcohol abuse. There
was no remarkable family history. On admission, vital signs (blood
http://dx.doi.org/10.1016/j.ijscr.2015.07.021
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. T2 weighted axial MRI  image (red arrow shows the spleen and yellow arrow
shows the mass which is centrally hyperintense and periferally hypointense). (For
interpretation of the references to color in this figure legend, the reader is referred
to  the web version of this article.)
pressure, heart rate, respiration rate, and body temperature) were
within normal limits. There was no peripheral lymphadenopathy,
hepatomegaly or splenomegaly in physical examination. The initial
blood examination showed marked anemia (Hb = 7.6 g/dl), reduced
leukocyte count (2100/cu mm)  with neutropenia and lymphopenia
and a marked reduction in the platelet count (70,000 platelets/cu
mm).  A repeat complete blood count (CBC) showed similar results.
Basic metabolic panel, chest X-ray film, and electrocardiogram
results were all normal. Tumor marker assays showed that alpha-
fetoprotein was 7.2 n/ml (normal 0–8.1), carcinoembryonic antigen
(CEA) was 3 ng/ml (normal 0–5), carbohydrate antigen 19–9 (CA
19–9) was 11 U/ml (normal 0–37).
The patient was admitted for evaluation of her pancytope-
nia by haematology department. All the results, testing for
human immunodeficiency virus (HIV), Epstein–Barr virus (EBV),
cytomegalovirus, hepatitis, parvovirus B19, and antinuclear anti-
bodies were negative. B12 and folate levels were in normal limits.
Upper GI endoscopy and colonoscopy were also normal. Then
bone marrow aspiration was performed to evaluate the cause of
pancytopenia. The aspirate was normocellular and showed nor-
mal  maturation of all the three series. The bone marrow reaction
was normoblastic. Abdominal USG was performed to revealed the
dimensions of the spleen. A 8 × 7 size cm mass from pancreatic
tail to splenic hilum was observed in the abdominal USG. Mag-
netic resonance imaging revealed a 8 × 7 × 8 cm sized mass closed
to the pancreatic tail invading splenic hilum(Fig. 1). The patient
underwent a laparotomy with a median superior incision. A large
mass was identified retroperitoneally, closed to the tail of pancreas
with a splenic vein occlusion. Total mass resection and splenec-
tomy was performed(Fig. 2). Mean operative time was 120 min  and
mean blood loss was 200 cc. A significant improvement in the total
leucocyte and platelet count was seen on the third day of surgery.
There was an increase in the haemoglobin concentration but was
the last parameter to show improvement. Her platelet count was
abnormally elevated to 677,000 platelets/cu mm  postoperative day
6. The patient remained asymptomatic at discharge, and the recom-
mendations for reactive thrombocytosis after splenectomy were
discussed with her. We  recommended mobilization and increased
fluid intake. She was started on 100 mg  of aspirin daily. The patient
Fig. 2. Grossly characteristic brown appearence of the tumor. Tumor mass is well-
surcumscribed with a fibrous capsule.
was discharged after 7 postoperative day. One month following
surgery, blood counts were in normal limits. Pathological exami-
nation of the specimen was reported as paraganglioma(Fig. 3).
At 6-months follow-up, the patient’s complete blood count
remains normal and abdominal CT did not reveal any recurrence
of the mass.
3. Discussion
Paragangliomas are extra-adrenal chromaffin tumours that
develop at the expense of neuroectodermal cells of the autonomous
nervous system [5]. Paragangliomas can develope at various sites of
the body including the head, neck, thorax and the abdomen. Despite
most of the paragangliomas are asymptomatic, retroperitoneal and
nonfunctioning forms are very rare [6]. The first imaging modality
in the diagnosis of extra-adrenal paragangliomas is magnetic reso-
nance imaging (MRI) secondary to superior tissue characterization
and absence of radiation hazards [7]. Computerized tomogra-
phy (CT) scan also has sensitivity of around 90% for identifying
extra-adrenal paragangliomas and they appear as highly vascu-
lar structure with areas of intralesional hemorrhage and necrosis
[8]. Metaiodobenzylguanidine scintigraphy (MIBG scintigraphy)
has often been used as an imaging modality in the diagnosis of
neuroendocrine tumors, but it lacks sensitivity for extra-adrenal
paragangliomas [1].
Complete surgical excision is the treatment of choice for extra-
adrenal paragangliomas as well as for recurrent or metastatic
neoplasms [2]. Patient with metastatic disease will require adju-
vant radiotherapy while chemotherapy is restricted to patients not
accessible for surgery and resistant to radionuclide therapy [9].
Reactive thrombocytosis is a common cause of thrombocyto-
sis [10]. Splenectomy was  found to be one of the main causes of
extreme reactive thrombocytosis as in the present case [11]. Reac-
tive thrombocytosis is a predictable finding after splenectomy, with
the platelet count peaking at 1 to 3 weeks and returning to normal
levels in weeks, months, and, rarely, years [12]. Essential throm-
bocytosis is not a well-recognized cause for arterial and venous
thrombosis. Management of the thrombocytosis and prevention of
complications should be initiated [13]. The first line of therapy is
the administration of platelet-antiaggregating medication such as
aspirin [14].
Histopathological findings are not much useful to differenti-
ate between benign and malignant paragangliomas only extensive
local invasion and distant metastasis to liver, bone, and lymph
nodes have been used as indicators for malignancy [1,8]. Follow-
up imaging is necessary in cases of patients with elevated
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Fig. 3. (A): Chromogranin A: Tumor cells are diffusely positive for neuroendocrine marker Chromogranin A immunohistochemically. (B): H&E: Well defined nests of cuboidal
cells  separated by highly vascularized fibrous septa. Individual cells have a moderately abundant granular basophilic cytoplasm.
metanephrine and catecholamine levels or with non functional
original tumors [3]. Because of malignant potential and higher
recurrence rate in paragangliomas, lifelong followup is always rec-
ommended [15].
4. Conclusion
Paragangliomas are very rare entities and has never been
reported before manifesting with pancytopenia. Surgical resec-
tion is still the main treatment and necessary for histological
assessment. Reactive thrombocytosis is a predictable finding after
splenectomy as in the present case. Management of the thrombocy-
tosis and prevention of complications should be kept in mind after
splenectomy.
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